Bone density loss after risk reducing salpingo-oophorectomy
نویسندگان
چکیده
Women undergoing risk-reducing salpingo-oophorectomy through the Prince of Wales Hospital Hereditary Cancer Clinic are offered enrolment in a prospective study of bone mineral density (BMD), markers of bone metabolism and cardio-vascular risk factors. Participants are invited to enroll a friend who has ovaries in situ and are aged within five years of the participant as a control population. Lumbar spine (LS), femoral neck (FN) and total body (TB) bone mineral density changes as a percentage annual loss are reported and compared with age matched norm. Women who were pre-menopausal at the time of oophorectomy have been compared with those who were either already post-menopausal at oophorectomy or had ovaries in situ to evaluate the impact of this intervention. 59 women have been enrolled and have now had 2 or more bone density evaluations – 44 cases and 15 controls. 7 women who were taking HRT or drugs affecting bone metabolism at entry were excluded from this analysis. The average age of women who had undergone pre-menopausal RRSO was 48.4yrs and 49.4yrs for the comparison group. Of those who were still menstruating at the time of RRSO and were not taking HRT at enrolment, the average annual decrease in LS BMD from year 1 to year 2 was 1.3% of enrolment value, in FN was 0.95% and in TB BMD was 0.6%.The corresponding decrease for the comparison group was 0.88% in LS, 1.3% in FN and an increase of 0.26% for TB. Both groups are aged under 50 and demonstrate a greater than average BMD loss compared with age matched norms (population average annual LS loss is 0.35% in pre-menopausal women and 0.9% for women in early menopause)[1]. The small cohorts so far do not demonstrate any statistically significant differences, but recruitment is ongoing. These findings are consistent with established data which has shown that LS has the greatest loss of BMD in the early menopausal years, with stable or even increasing whole total body BMD. Data will be presented on total body fat and fat distribution changes in these cohorts.
منابع مشابه
Salpingectomy With Delayed Oophorectomy in BRCA1/2 Mutation Carriers: Estimating Ovarian Cancer Risk.
OBJECTIVE To estimate BRCA1/2 mutation carriers' cumulative ovarian cancer risks after risk-reducing salpingectomy at various ages with delayed oophorectomy several years later compared with risk-reducing salpingo-oophorectomy. METHODS A literature search was performed on cumulative ovarian cancer risks and effects of risk-reducing salpingo-oophorectomy and salpingectomy. Results were used in...
متن کاملWhat Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women
INTRODUCTION Women at high inherited risk of ovarian cancer are advised to undergo risk-reducing bilateral salpingo-oophorectomy (RRBSO) at age 40-45 years or when their families are complete. Most women are premenopausal at this age, so RRBSO will induce surgical menopause. Despite the clear benefits of RRBSO for cancer risk reduction, much less is known about the impact on non-cancer outcomes...
متن کاملElevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer
BACKGROUND Risk-reducing salpingo-oophorectomy (RRSO) reduces ovarian cancer risk in BRCA1/2 mutation carriers. Premenopausal RRSO is hypothesized to increase fracture risk more than natural menopause. Elevated bone turnover markers (BTMs) might predict fracture risk. We investigated BTM levels after RRSO and aimed to identify clinical characteristics associated with elevated BTMs. METHODS Os...
متن کاملRisk-reducing appendectomy and the elimination of BRCA1-associated intraperitoneal cancer.
Risk-reducing bilateral salpingo-oophorectomy (RRBSO) and risk-reducing mastectomy are widely used for BRCA1 and BRCA2 mutation carriers to reduce the risk of ovarian and breast cancer. To our knowledge, no risk-reduction therapy has addressed the BCRA1/2 carrier lifetime risk of intra-abdominal peritoneal carcinoma from an appendix source. We identified a BRCA1 carrier in a hereditary breast a...
متن کاملExperience of risk-reducing salpingo-oophorectomy for a BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: our challenges for the future.
BACKGROUND Risk-reducing salpingo-oophorectomy is currently regarded as the most certain primary method for preventing ovarian cancer among BRCA1/2 mutation carriers with hereditary breast and ovarian cancer syndrome. However, risk-reducing salpingo-oophorectomy has rarely been performed in Japan. METHODS We developed the first system in Japan for performing risk-reducing salpingo-oophorectom...
متن کامل